PL319440A1 - Analoques of antiviral nuceosides containing substituted benzimidazoles attached to the carbocyclic ring - Google Patents
Analoques of antiviral nuceosides containing substituted benzimidazoles attached to the carbocyclic ringInfo
- Publication number
- PL319440A1 PL319440A1 PL95319440A PL31944095A PL319440A1 PL 319440 A1 PL319440 A1 PL 319440A1 PL 95319440 A PL95319440 A PL 95319440A PL 31944095 A PL31944095 A PL 31944095A PL 319440 A1 PL319440 A1 PL 319440A1
- Authority
- PL
- Poland
- Prior art keywords
- nuceosides
- analoques
- antiviral
- attached
- carbocyclic ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/304,006 US5534535A (en) | 1992-03-09 | 1994-09-09 | Therapeutic nucleosides |
Publications (1)
Publication Number | Publication Date |
---|---|
PL319440A1 true PL319440A1 (en) | 1997-08-04 |
Family
ID=23174626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL95319440A PL319440A1 (en) | 1994-09-09 | 1995-09-11 | Analoques of antiviral nuceosides containing substituted benzimidazoles attached to the carbocyclic ring |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0779885A1 (en) |
JP (1) | JPH10505092A (en) |
CN (1) | CN1164855A (en) |
AP (1) | AP741A (en) |
AU (1) | AU3692895A (en) |
BR (1) | BR9508826A (en) |
CA (1) | CA2199502A1 (en) |
CZ (1) | CZ71297A3 (en) |
FI (1) | FI970959A (en) |
HU (1) | HUT77440A (en) |
IS (1) | IS4436A (en) |
NO (1) | NO971070L (en) |
NZ (1) | NZ294095A (en) |
OA (1) | OA10601A (en) |
PL (1) | PL319440A1 (en) |
SK (1) | SK29197A3 (en) |
WO (1) | WO1996007646A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5912356A (en) * | 1995-09-11 | 1999-06-15 | Glaxo Wellcome Inc. | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
GB9600142D0 (en) * | 1996-01-05 | 1996-03-06 | Wellcome Found | Chemical compounds |
DE69819695D1 (en) | 1997-02-13 | 2003-12-18 | Glaxo Group Ltd | Benzimidazolderivate |
NZ502882A (en) | 1997-07-30 | 2002-02-01 | Glaxo Group Ltd | Lyxofuranosyl benzimidazoles as antiviral agents |
CN1623984A (en) | 1999-12-27 | 2005-06-08 | 日本烟草产业株式会社 | Fused-ring compounds and use thereof as drugs |
US6770666B2 (en) | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
AR035543A1 (en) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | THERAPEUTIC AGENT FOR HEPATITIS C THAT INCLUDES A CONDENSED RING COMPOUND, CONDENSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS, BENZIMIDAZOL, THIAZOL AND BIFENYL COMPOUNDS USED AS INTERMEDIARY COMPARTMENTS OF COMPARTMENTS |
CN1834090B (en) * | 2005-03-18 | 2011-06-29 | 中国科学院上海药物研究所 | Benzimidazole compounds, its preparation and uses |
CN106243111B (en) | 2007-08-02 | 2019-07-23 | 米伦纽姆医药公司 | The method for synthesizing E1 activating enzyme inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
-
1995
- 1995-09-11 PL PL95319440A patent/PL319440A1/en unknown
- 1995-09-11 NZ NZ294095A patent/NZ294095A/en unknown
- 1995-09-11 WO PCT/US1995/011366 patent/WO1996007646A1/en not_active Application Discontinuation
- 1995-09-11 EP EP95934402A patent/EP0779885A1/en not_active Withdrawn
- 1995-09-11 SK SK291-97A patent/SK29197A3/en unknown
- 1995-09-11 CN CN95196148A patent/CN1164855A/en active Pending
- 1995-09-11 CZ CZ97712A patent/CZ71297A3/en unknown
- 1995-09-11 HU HU9702310A patent/HUT77440A/en unknown
- 1995-09-11 BR BR9508826A patent/BR9508826A/en not_active Application Discontinuation
- 1995-09-11 AP APAP/P/1997/000940A patent/AP741A/en active
- 1995-09-11 AU AU36928/95A patent/AU3692895A/en not_active Abandoned
- 1995-09-11 CA CA002199502A patent/CA2199502A1/en not_active Abandoned
- 1995-09-11 JP JP8509679A patent/JPH10505092A/en not_active Ceased
-
1997
- 1997-03-06 FI FI970959A patent/FI970959A/en unknown
- 1997-03-07 NO NO971070A patent/NO971070L/en unknown
- 1997-03-07 IS IS4436A patent/IS4436A/en unknown
- 1997-03-07 OA OA60973A patent/OA10601A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO971070D0 (en) | 1997-03-07 |
MX9701789A (en) | 1997-10-31 |
NZ294095A (en) | 1998-08-26 |
FI970959A (en) | 1997-05-06 |
EP0779885A1 (en) | 1997-06-25 |
AU3692895A (en) | 1996-03-27 |
FI970959A0 (en) | 1997-03-06 |
HUT77440A (en) | 1998-04-28 |
CZ71297A3 (en) | 1997-08-13 |
AP741A (en) | 1999-04-26 |
CA2199502A1 (en) | 1996-03-14 |
SK29197A3 (en) | 1997-10-08 |
JPH10505092A (en) | 1998-05-19 |
WO1996007646A1 (en) | 1996-03-14 |
BR9508826A (en) | 1997-09-30 |
CN1164855A (en) | 1997-11-12 |
AP9700940A0 (en) | 1997-04-30 |
NO971070L (en) | 1997-05-07 |
OA10601A (en) | 2002-09-03 |
IS4436A (en) | 1997-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3035574T3 (en) | Use of substituted benzimidazoles. | |
ZA918685B (en) | Polysubstituted benzimidazoles as antiviral agents | |
DE69329140D1 (en) | Direct conversion recipient | |
EP0239001A3 (en) | Fender protective structures | |
IL98918A0 (en) | Carbocyclic analogs of certain nucleosides | |
GB9207131D0 (en) | Conversion of ginkgolide c to ginkgolide b | |
PL319440A1 (en) | Analoques of antiviral nuceosides containing substituted benzimidazoles attached to the carbocyclic ring | |
IL111029A0 (en) | Intermediates to indolones | |
GB9207624D0 (en) | Improvements relating to the protection of corrosion-susceptible members | |
GB8607265D0 (en) | Protecting groups of organic synthesis | |
ZA93144B (en) | Substituted benzimidazole derivatives | |
FR2766916B1 (en) | TURRET OF CHAR | |
EP0450823A3 (en) | The conversion of amines to hydroxylamines | |
EP0583161A3 (en) | 4-aminopyrrole-2-carboxamide derivatives as antiviral agents | |
GB9223200D0 (en) | Improvements to electrocardiagraphs | |
GB9221571D0 (en) | Improvements relating to ladders | |
LTIP1738A (en) | The pharmacological use of certain cystine derivatives | |
HU9400358D0 (en) | Use of quinoziline derivatives as orexigenics | |
GB9203392D0 (en) | Improvements relating to the construction of anemometers | |
GB9205652D0 (en) | Worktray for attachment to ladders | |
GB2262984B (en) | Conversion of points to lines | |
GB8813107D0 (en) | Purification of aluminium | |
GB9025322D0 (en) | Improvements relating to the extrusion of pastes | |
AU116185S (en) | Conversion ring | |
GB9211051D0 (en) | Improvements relating to the extrusion of paste |